Interesting post from the IV MB wrt filing a NDA if results of an interinm analysis are statistically significant. With 9902b, Vital-1 and possibly Vital-2 reporting interin results in 2008, it could be an interesting year for cancer immunotherapies.http://www1.investorvillage.com/smbd.asp?mb=971&mn=154080&pt=msg&mid=2940983
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.